Treatment | Maintenance of LDA at Yr 8 | ΔmTSS From Yr 2 to Yr 8 | ||
---|---|---|---|---|
% (n/N)a | % (n/N)b | Mean ± SDb | ΔmTSS ≤0.5, % (n/N)b | |
OL ADA Monotherapy | 50 (87/173) | 88 (87/99) | 2.4±6.4 | 49 (47/96) |
aNon-responder imputation. bData as observed. ΔmTSS, change in modified total Sharp score; Yr, year; SD, standard deviation; OL, open-label; ADA, adalimumab.